About
Altimmune Inc (NASDAQ:ALT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
Apr 23 2026
Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities
Apr 22 2026
Altimmune Announces Proposed Underwritten Public Offering of Securities
Mar 5 2026
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
Feb 26 2026
Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
Financials
Revenue
$41 K
Market Cap
$434.55 M
EPS
-1.00
Google Übersetzer